Search bioRxiv⌕ Search

Biology subjects

Cameron, J. J.

Publications and source records attributed to Cameron, J. J..

2 recordsLinked to original sources

Dot1L-mediated H3K79 methylation licenses TET-dependent DNA demethylation to establish Treg identity

Foxp3+ regulatory T (Treg) cells rely on DNA demethylation to establish and maintain the gene expression program that defines their identity and suppressive function. Although sustained transcription of Treg-specific genes is known to drive this demethylation, the precise mechanism has remained unclear. Here, we show that Dot1L-catalyzed methylation of histone H3 at lysine 79 (H3K79me) is essential for Treg-specific DNA demethylation in both thymic and induced Treg lineages. H3K79me promotes chromatin activation and recruits TET family DNA demethylases to key regulatory loci. Treg-restricted deletion of Dot1L disrupts locus-specific DNA demethylation, diminishes expression of core Treg genes, and precipitates a fatal, early-onset autoimmune syndrome. Conversely, pharmacologic enhancement of TET activity during differentiation rescues DNA demethylation, restores Treg-gene expression, and reinstates suppressive function even in the presence of Dot1L inhibition. Together, these findings identify a critical epigenetic axis--Dot1L-mediated H3K79 methylation driving TET-dependent DNA demethylation--that safeguards Treg cellular identity, function, and immune homeostasis.

immunology↗

Regulatory T cells epigenetically reprogrammed from autoreactive effector T cells mitigate established autoimmunity

Reprogramming autoreactive CD4+ effector T (Teff) cells into immunosuppressive regulatory T (Treg) cells represents a promising strategy for treating established autoimmune diseases. However, the stability and function of such reprogrammed Tregs under inflammatory conditions remain unclear. Here, we show that demethylation of core Treg identity genes in Teff cells yields lineage-stable Effector T cell Reprogrammed Tregs (ER-Tregs). A single adoptive transfer of ER-Tregs not only prevents autoimmune neuroinflammation in mice when given before disease onset but also arrests its progression when administered after onset. Compared to Foxp3-overexpressing Teff cells, induced Tregs from naive precursors, and endogenous Tregs, ER-Tregs provide superior protection against autoimmune neuroinflammation. This enhanced efficacy stems from their inherited autoantigen specificity and selectively preserved effector-cell transcriptional programs, which together bolster their fitness in inflammatory environments and enhance their suppressive capacity. Our results establish epigenetic reprogramming of autoreactive Teff cells as an effective approach to generate potent, stable Tregs for the treatment of refractory autoimmune conditions.

immunology↗